A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

NCT02598440 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Alendronate
DRUG: Ibandronate

Sponsor

Hoffmann-La Roche